EPISODE · Jun 8, 2026 · 4 MIN
今天3分钟我们来聊聊NK细胞治疗晚期前列腺癌
from 源于细胞BioInsid的个人播客
中国男性前列腺癌每年新发超11万例，多数确诊时已难手术根治。传统治疗易耐药，免疫治疗因前列腺癌是“冷肿瘤”效果差。NK细胞无需特定靶点即可识别癌细胞，补充高活性NK细胞能有效治疗。博鳌乐城数据显示，NK细胞治疗中位总生存期41.6个月，2年生存率58.3%，且安全性高，真实病例生活质量显著改善。参考文献：博鳌乐城NK细胞治疗实体瘤临床数据Nature Medicine，2025，PSMA靶向治疗综述FDA Sipuleucel-T（Provenge）批准文件，2010微信公众号「源于细胞BioInside」，《确诊前列腺癌那天，我在诊室里坐了半小时——NK细胞给了晚期患者第三条路》前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊NK细胞治疗晚期前列腺癌
0:00
4:31
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 4 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on June 8, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!